Pursuant to Regulation 40 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Parabolic Drugs has informed about Compliance Report on Transfer or Transmission or Transposition of Securities of the Company for the Quarter/ Half Year ended on 30th September, 2018.
The above information is a part of company’s filings submitted to BSE.